CellSeed Management

Management criteria checks 1/4

We currently do not have sufficient information about the CEO.

Key information

Setsuko Hashimoto

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenure10.6yrs
CEO ownership0.1%
Management average tenureno data
Board average tenure5.8yrs

Recent management updates

Recent updates

Is CellSeed (TYO:7776) In A Good Position To Invest In Growth?

Nov 17
Is CellSeed (TYO:7776) In A Good Position To Invest In Growth?

CEO

Setsuko Hashimoto (71 yo)

10.6yrs

Tenure

Ms. Setsuko Hashimoto, Ph.D. has been President of CellSeed Inc. since June 1, 2014 and has been its Chief Executive Officer since June 1, 2014 and Representative Director since March 2014.


Board Members

NamePositionTenureCompensationOwnership
Setsuko Hashimoto
CEO, President & Representative Director10.8yrsno data0.096%
¥ 13.2m
Toshio Yamaguchi
Independent Outside Director3.8yrsno datano data
Kenji Oeda
Independent Outside Director7.8yrsno data0.013%
¥ 1.8m
Yukiko Endo
Independent Outside Director1.8yrsno datano data

5.8yrs

Average Tenure

70.5yo

Average Age

Experienced Board: 7776's board of directors are considered experienced (5.8 years average tenure).


Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/03 04:59
End of Day Share Price 2024/12/30 00:00
Earnings2021/12/31
Annual Earnings2021/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

CellSeed Inc. is covered by 3 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Kiyokazu YamazakiIchiyoshi Research Institute Inc.
null nullInvestment Bridge Co., Ltd.
Kyoichiro ShigemuraNomura Securities Co. Ltd.